<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36103331</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.</ArticleTitle><Pagination><StartPage>2510</StartPage><EndPage>2519</EndPage><MedlinePgn>2510-2519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2125346</ELocationID><Abstract><AbstractText>Three inactivated enterovirus A71 (EV-A71) vaccines have been widely vaccinated among children in the targeted age group in mainland China since mid-2016. However, comprehensive virological surveillance of hand, foot and mouth disease (HFMD) over multiple years after the use of EV-A71 vaccines has rarely been conducted. Using long-term data extracted from the Public Health and Clinical Center of Chengdu, we described the clinical, aetiological, and epidemiological characteristics of HFMD inpatients after the use of EV-A71 vaccines from 2017 through 2022. A total of 5115 patients were selected for analysis with a male-to-female ratio of 1.63:1 and were mostly under 5 years of age (97.6%). Among these cases, 4.3% presented with severe symptoms, and 4.1% of severe cases experienced significant complications. EV-A71 was no longer the major serotype for laboratory-confirmed HFMD, responsible for 15.6% of severe cases and 1.2% of mild cases. A significant downwards trend of EV-A71 infections was observed after the use of EV-A71 vaccines (P for trend &lt; 0.001). Coxsackievirus A6 was the predominant pathogen, accounting for 63.5% of mild cases and 36.2% of severe cases. Coxsackievirus A10 (CV-A10) and A16 were sporadically detected, and an upwards trend was observed in the proportion of CV-A10 infections. This study provides baseline molecular epidemiology for the evaluation of EV-A71 vaccination impact and potential serotype replacement based on HFMD inpatients. Additional nationwide and population-based epidemiologic and serologic studies are essential to elucidate HFMD dynamics after the use of EV-A71 vaccines, and to inform public health authorities to introduce optimized intervention strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Xiaoxia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chaoyong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Public Health Clinical Center of Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Xueling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liangzhi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunization Program, Chengdu Municipal Center for Disease Control and Prevention, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology Laboratory, Chengdu Municipal Center for Disease Control and Prevention, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Mengmou</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Wanzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Yilan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Public Health Clinical Center of Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015721">Diphtheria-Tetanus-Pertussis Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>16VY3TM7ZO</RegistryNumber><NameOfSubstance UI="C052091">antineoplaston A10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001500">BCG Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022261">Respiratory Syncytial Virus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018449">SAIDS Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053918">Papillomavirus Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015721" MajorTopicYN="N">Diphtheria-Tetanus-Pertussis Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016915" MajorTopicYN="Y">AIDS Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001500" MajorTopicYN="N">BCG Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022261" MajorTopicYN="Y">Respiratory Syncytial Virus Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018449" MajorTopicYN="Y">SAIDS Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053918" MajorTopicYN="Y">Papillomavirus Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71 vaccine</Keyword><Keyword MajorTopicYN="N">Hand foot and mouth disease</Keyword><Keyword MajorTopicYN="N">clinical features</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">molecular epidemiology</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36103331</ArticleId><ArticleId IdType="pmc">PMC9621254</ArticleId><ArticleId IdType="doi">10.1080/22221751.2022.2125346</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, et al. . Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097–1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B, Levent F.. Hand, foot, and mouth disease. Jama. 2018;320(23):2492.</Citation><ArticleIdList><ArticleId IdType="pubmed">30561482</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses ICoTo . ICTV Virus Taxonomy (2021 Release) 2021 [cited 2022 20 July]. Available from: https://talk.ictvonline.org/taxonomy/.</Citation></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. . Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308–318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, et al. . The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-pacific region. J Biomed Sci. 2019;26(1):75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chang Z, Wu P, et al. . Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016. Emerging Infect Dis. 2018;24(10):1902–1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao TS, Du J, Sun DP, et al. . A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications. Rev Med Virol. 2020 Mar;30(2):e2087.</Citation><ArticleIdList><ArticleId IdType="pubmed">31811676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M, Tarragó D, Muñoz-Almagro C, et al. . Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect. 2014;20(3):O150–O156.</Citation><ArticleIdList><ArticleId IdType="pubmed">24033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Wan Z, Li Y, et al. . National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin. 2020;35(1):21–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, et al. . Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh HL, Mohammad SS, Britton PN, et al. . Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol. 2016;73(3):300–307.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, et al. . EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15(5):599–606.</Citation><ArticleIdList><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Li JX, Jin PF, et al. . Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines. 2016;15(7):803–813.</Citation><ArticleIdList><ArticleId IdType="pubmed">27206811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang L, Zhang C, et al. . The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319–3323.</Citation><ArticleIdList><ArticleId IdType="pubmed">33994239</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention CCfDCa . Overview of the National Epidemic of Notifiable Infectious Diseases in China (2021) 2022 [cited 2022 11th, May]. Available from: http://www.nhc.gov.cn/jkj/s3578/202204/4fd88a291d914abf8f7a91f6333567e1.shtml.</Citation></Reference><Reference><Citation>Xiaoli W, Hongxin W, Lei J, et al. . Summary of research in economic burden of hand, foot, and mouth disease in China (in Chinese) [review]. Chin J Epidemiol. 2020;41(02):273–279.</Citation><ArticleIdList><ArticleId IdType="pubmed">32164141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Teng Z, Cui X, et al. . MALDI-TOF MS for identification oftsukamurellaspecies:tsukamurella tyrosinosolvensas the predominant species associated with ocular infections. Emerg Microbes Infect. 2018;7(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5940693</ArticleId><ArticleId IdType="pubmed">29739926</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Zou G, Liao Q, et al. . Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis 2018;67(11):1729–1735.</Citation><ArticleIdList><ArticleId IdType="pubmed">29688329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai Y, Zhang W, Wu J, et al. . Molecular epidemiology and clinical features of enteroviruses-associated hand, foot, and mouth disease and herpangina outbreak in zunyi, China, 2019. Front Med (Lausanne). 2021;8:656699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8109248</ArticleId><ArticleId IdType="pubmed">33981716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang Z, Rao Q, et al. . The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in kunming, China. Emerg Microbes Infect. 2021;10(1):619–628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="pubmed">33682641</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XW, Ni X, Qian SY, et al. . Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;14(5):437–447.</Citation><ArticleIdList><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick Giraudoux ORCID iD [aut c, Jean-Philippe Antonietti [ctb], Colin Beale [ctb], Renaud Lancelot [ctb], David Pleydell [ctb], Mike Treglia [ctb]. pgirmess: Spatial Analysis and Data Mining for Field Ecologists (Version 2.0.0) 2022 [updated February 23, 2022; cited 2022 June 21]. Available from: https://cran.r-project.org/web/packages/pgirmess/pgirmess.pdf.</Citation></Reference><Reference><Citation>Head JR, Collender PA, Lewnard JA, et al. . Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011-2018: A longitudinal surveillance study. Clin Infect Dis 2020;71(12):3088–3095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819528</ArticleId><ArticleId IdType="pubmed">31879754</ArticleId></ArticleIdList></Reference><Reference><Citation>Xinhua . Hand, foot and mouth disease on rise in Beijing Beijing2018 [cited 2022 20th June]. Available from: http://www.chinadaily.com.cn/a/201807/04/WS5b3c6e64a3103349141e0a93.html.</Citation></Reference><Reference><Citation>Han Y, Chen Z, Zheng K, et al. . Epidemiology of hand, foot, and mouth disease before and after the introduction of enterovirus 71 vaccines in chengdu, China, 2009-2018. Pediatr Infect Dis J. 2020;39(10):969–978.</Citation><ArticleIdList><ArticleId IdType="pubmed">32433221</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Xu Y, Zhu Y, et al. . Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China. Hum Vaccin Immunother. 2021;17(11):4083–4089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828147</ArticleId><ArticleId IdType="pubmed">34374635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Liu F, Liao Q, et al. . Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017 Dec;22(50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J, Yan H, Cheng N, et al. . The clinical and epidemiological study of children with hand, foot, and mouth disease in hunan, China from 2013 to 2017. Sci Rep. 2019;9(1):11662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690890</ArticleId><ArticleId IdType="pubmed">31406192</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SL, Pan H, Liu P, et al. . Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol 2015;25(2):115–128.</Citation><ArticleIdList><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsuwanon P, Puenpa J, Huang SW, et al. . Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci 2014;21(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937078</ArticleId><ArticleId IdType="pubmed">24548776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Fan H, Lu PX, et al. . Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis 2019;19(1):79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341624</ArticleId><ArticleId IdType="pubmed">30669973</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YR, Sun LL, Xiao WL, et al. . Epidemiology and clinical characteristics of hand foot, and mouth disease in a shenzhen sentinel hospital from 2009 to 2011. BMC Infect Dis 2013;13:539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829808</ArticleId><ArticleId IdType="pubmed">24225231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Maimaiti H, Zhou L, et al. . Changing serotypes of hand, foot and mouth disease in Shanghai, 2017-2019. Gut Pathog. 2022;14(1):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935267</ArticleId><ArticleId IdType="pubmed">35313977</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z, Song Y, Xiao J, et al. . Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity. Virus Evol. 2020;6(2):veaa084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597624</ArticleId><ArticleId IdType="pubmed">34804589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Shi Y, Miao L, et al. . Molecular epidemiology and recombination of enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol. 2021;24(3):291–299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7895512</ArticleId><ArticleId IdType="pubmed">33608776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Gao M, Cui D.. Molecular characteristics of the VP1 region of enterovirus 71 strains in China. Gut Pathog. 2020;12:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427758</ArticleId><ArticleId IdType="pubmed">32818043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T, Han T, Tan X, et al. . Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety and Health. 2019;1(1):32–40.</Citation></Reference><Reference><Citation>Song Y, Zhang Y, Ji T, et al. . Persistent circulation of coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci Rep. 2017;7(1):5491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5511160</ArticleId><ArticleId IdType="pubmed">28710474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, le Sage FV, Pereira B, et al. . Ambulatory pediatric surveillance of hand, foot and mouth disease as signal of an outbreak of coxsackievirus A6 infections, France, 2014-2015. Emerging Infect Dis. 2016;22(11):1884–1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5088007</ArticleId><ArticleId IdType="pubmed">27767012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, et al. . Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13(9):1061–1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lin C, Qu M, et al. . Excretion of enterovirus 71 in persons infected with hand, foot and mouth disease. Virol J. 2013;10:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3560202</ArticleId><ArticleId IdType="pubmed">23343115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>